ascendis transcon glp-1 program Novo Nordisk Signs $285M Deal With Danish Neighbor TransCon CNP | Ascendis Pharma
Description
Kenneth Palmer, orthopedic surgeon specializing in spine surgery at Houston Methodist

Nimm deine gesamte Bibliothek einfach mit Deine Lieblingsgeschichten sind immer dabei

Should I be worried
It is about preserving functional independence

Clinical trial data provides insight into the frequency of hair loss reported by people taking different GLP-1 and dual-agonist medications for weight management

What excites me most isn't just the medication itself but it's how it's reshaping our understanding of obesity as a chronic disease rather than a personal failure
